279 related articles for article (PubMed ID: 21567170)
21. Distant metastasis in triple-negative breast cancer.
Tseng LM; Hsu NC; Chen SC; Lu YS; Lin CH; Chang DY; Li H; Lin YC; Chang HK; Chao TC; Ouyang F; Hou MF
Neoplasma; 2013; 60(3):290-4. PubMed ID: 23373998
[TBL] [Abstract][Full Text] [Related]
22. Recurrent breast cancer: factors influencing survival, including treatment.
Pearlman NW; Jochimsen PR
J Surg Oncol; 1979; 11(1):21-9. PubMed ID: 431079
[TBL] [Abstract][Full Text] [Related]
23. Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment.
Berman AT; Thukral AD; Hwang WT; Solin LJ; Vapiwala N
Clin Breast Cancer; 2013 Apr; 13(2):88-94. PubMed ID: 23218473
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in 401 elderly women with metastatic breast cancer.
Follana P; Barrière J; Chamorey E; Largillier R; Dadone B; Mari V; Hannoun-Levi JM; Marcy M; Flipo B; Ferrero JM
Oncology; 2014; 86(3):143-51. PubMed ID: 24577186
[TBL] [Abstract][Full Text] [Related]
25. Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.
Thangarajah F; Vogel C; Pahmeyer C; Eichler C; Holtschmidt J; Ratiu D; Mallmann P; Malter W
Anticancer Res; 2018 Oct; 38(10):6023-6026. PubMed ID: 30275235
[TBL] [Abstract][Full Text] [Related]
26. Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.
Orlando L; Cardillo A; Ghisini R; Rocca A; Balduzzi A; Torrisi R; Peruzzotti G; Goldhirsch A; Pietri E; Colleoni M
BMC Cancer; 2006 Sep; 6():225. PubMed ID: 16978400
[TBL] [Abstract][Full Text] [Related]
27. Supportive and palliative care for metastatic breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement.
Cleary J; Ddungu H; Distelhorst SR; Ripamonti C; Rodin GM; Bushnaq MA; Clegg-Lamptey JN; Connor SR; Diwani MB; Eniu A; Harford JB; Kumar S; Rajagopal MR; Thompson B; Gralow JR; Anderson BO
Breast; 2013 Oct; 22(5):616-27. PubMed ID: 23972474
[TBL] [Abstract][Full Text] [Related]
28. Cerebral metastases in metastatic breast cancer: disease-specific risk factors and survival.
Heitz F; Rochon J; Harter P; Lueck HJ; Fisseler-Eckhoff A; Barinoff J; Traut A; Lorenz-Salehi F; du Bois A
Ann Oncol; 2011 Jul; 22(7):1571-1581. PubMed ID: 21059640
[TBL] [Abstract][Full Text] [Related]
29. Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer.
Parikh RB; Cronin AM; Kozono DE; Oxnard GR; Mak RH; Jackman DM; Lo PC; Baldini EH; Johnson BE; Chen AB
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):880-7. PubMed ID: 24867533
[TBL] [Abstract][Full Text] [Related]
30. [CBDCA, etoposide and epirubicin high-dose combination chemotherapy supported by peripheral blood stem cell transplantation (PBSCT) in metastatic breast cancer].
Suwata J; Takada S; Murata N; Ishizuka N; Idezuki Y; Kobayashi M
Gan To Kagaku Ryoho; 1999 Jan; 26(1):83-8. PubMed ID: 9987502
[TBL] [Abstract][Full Text] [Related]
31. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.
Milano MT; Katz AW; Zhang H; Okunieff P
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):878-86. PubMed ID: 22172903
[TBL] [Abstract][Full Text] [Related]
32. Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer.
Onyenadum A; Gogas H; Markopoulos C; Bafaloukos D; Aravantinos G; Mantzourani M; Koutras A; Tzorakoelefterakis E; Xiros N; Makatsoris T; Fountzilas G; Kalofonos HP
J Chemother; 2007 Oct; 19(5):582-9. PubMed ID: 18073159
[TBL] [Abstract][Full Text] [Related]
33. Organ tropism in solid tumor metastasis: an updated review.
Mortezaee K
Future Oncol; 2021 May; 17(15):1943-1961. PubMed ID: 33728946
[TBL] [Abstract][Full Text] [Related]
34. Is there a favorable subset of patients with prostate cancer who develop oligometastases?
Singh D; Yi WS; Brasacchio RA; Muhs AG; Smudzin T; Williams JP; Messing E; Okunieff P
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):3-10. PubMed ID: 14697414
[TBL] [Abstract][Full Text] [Related]
35. A survival analysis of metastatic breast cancer in Pakistani patients.
Siddiqui T; Sabih M; Salam A; Khan S
J Pak Med Assoc; 2001 Mar; 51(3):120-2. PubMed ID: 11381825
[TBL] [Abstract][Full Text] [Related]
36. Long-term survival after autologous bone marrow transplantation for metastatic breast carcinoma.
Saez RA; Slease RB; Selby GB; Strnad C; Epstein RB; Confer DL
South Med J; 1995 Mar; 88(3):320-6. PubMed ID: 7886530
[TBL] [Abstract][Full Text] [Related]
37. The prognostic analysis of different metastatic patterns in extensive-stage small-cell lung cancer patients: a large population-based study.
Cai H; Wang H; Li Z; Lin J; Yu J
Future Oncol; 2018 Jun; 14(14):1397-1407. PubMed ID: 29359568
[TBL] [Abstract][Full Text] [Related]
38. Disparities in the survival improvement of recurrent breast cancer.
Anan K; Mitsuyama S; Koga K; Tanabe R; Saimura M; Tanabe Y; Watanabe M; Suehara N; Matsunaga H; Nishihara K; Abe Y; Nakano T; Tamae K; Ono M; Toyoshima S
Breast Cancer; 2010; 17(1):48-55. PubMed ID: 19350357
[TBL] [Abstract][Full Text] [Related]
39. Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
Ueno NT; Rondón G; Mirza NQ; Geisler DK; Anderlini P; Giralt SA; Andersson BS; Claxton DF; Gajewski JL; Khouri IF; Körbling M; Mehra RC; Przepiorka D; Rahman Z; Samuels BI; van Besien K; Hortobagyi GN; Champlin RE
J Clin Oncol; 1998 Mar; 16(3):986-93. PubMed ID: 9508181
[TBL] [Abstract][Full Text] [Related]
40. Multidisciplinary Tumor Board Recommendations for Oligometastatic Malignancies: A Prospective Single-Center Analysis.
Galata C; Wimmer E; Kasper B; Wenz F; Reißfelder C; Jakob J
Oncol Res Treat; 2019; 42(3):87-94. PubMed ID: 30814474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
